Open AccessShould Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower-Risk Patients With Early-Stage Breast Cancer?
Author(s) -
Vito Amoroso,
Rebecca Pedersini,
Phoebe Sharratt,
Lucia Vassalli,
Laura Ferrari,
Sandra Sigala,
Edda Simoncini,
Alfredo Berruti
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2014.58.7923
Subject(s) - medicine , paclitaxel , cyclophosphamide , oncology , adjuvant , breast cancer , stage (stratigraphy) , cancer , adjuvant chemotherapy , chemotherapy , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom